Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Shu-hong Yi"'
Autor:
Yun-Liang Xie, Zhou Yang, Xiao Feng, Qing Yang, Lin-Sen Ye, Xiao-Bin Li, Hui Tang, Ying-Cai Zhang, Wei Liu, Tong Zhang, Bin-Sheng Fu, Shu-Hong Yi, Yang Yang, Gui-Hua Chen
Publikováno v:
Asian Journal of Surgery, Vol 45, Iss 1, Pp 435-440 (2022)
Background: CTCs play a critical role in the diagnosis and prognosis of liver cancer. However, there are few studies on whether different types of CTCs can predict the prognosis in patients with HCC following LT. Methods: Retrospective data including
Externí odkaz:
https://doaj.org/article/daa44ffe9ad1437da602508754ced175
Publikováno v:
Liver Research, Vol 5, Iss 1, Pp 33-35 (2021)
Patients with recurrent hepatocellular carcinoma (HCC) following liver transplantation (LT) have a poor prognosis owing to rapid tumor progression. Yttrium-90 radioembolization (90Y-RE) has been shown to be a safe and efficacious transarterial radioe
Externí odkaz:
https://doaj.org/article/271787400a464750aa647eb9c08e9a45
Autor:
Nan Jiang, Kai-Ning Zeng, Ke-Feng Dou, Yi Lv, Jie Zhou, Hai-Bo Li, Jian-Xin Tang, Jin-Jun Li, Guo-Ying Wang, Shu-Hong Yi, Hui-Min Yi, Hua Li, Gui-Hua Chen, Yang Yang
Publikováno v:
Cellular Physiology and Biochemistry, Vol 48, Iss 1, Pp 317-327 (2018)
Background/Aims: Patient selection is critically important in improving the outcomes of liver transplantation for hepatocellular carcinoma. The aim of the current study was to identify biochemical measures that could affect patient prognosis after li
Externí odkaz:
https://doaj.org/article/9ccd7197781a4c0d985a13bb56c343ef
Autor:
Yingcai Zhang, Shu-hong Yi, Tianxing Dai, Yang Yang, Qing Yang, Linsen Ye, Guoying Wang, Wei Liu, Hua Li
Publikováno v:
Liver Research. 6:111-115
Immune checkpoint inhibitors are generally contraindicated for post-transplant patients. However, we report two patients with metastatic hepatocellular carcinoma (HCC) treated with camrelizumab (SHR-1210), an anti-programmed cell death 1 (PD-1) agent
Autor:
Yang Yang, Zhou Yang, Wei Liu, Qing Yang, Shu-hong Yi, Guihua Chen, Binsheng Fu, Xiao Feng, Yingcai Zhang, Yun-Liang Xie, Li Xiaobin, Linsen Ye, Tong Zhang, Hui Tang
Publikováno v:
Asian Journal of Surgery, Vol 45, Iss 1, Pp 435-440 (2022)
Background CTCs play a critical role in the diagnosis and prognosis of liver cancer. However, there are few studies on whether different types of CTCs can predict the prognosis in patients with HCC following LT. Methods Retrospective data including C
Autor:
Yang Yang, Lian-Xiong Yuan, Rongqin Zheng, Shu-hong Yi, Bowen Zheng, Jie Ren, Tao Wu, Yingcai Zhang, Mei Liao
Publikováno v:
Clinical Hemorheology and Microcirculation. 79:519-530
BACKGROUND: Biliary ischaemia is an important factor in the pathogenesis of non-anastomotic biliary stricture (NAS) after liver transplantation (LT). Contrast-enhanced ultrasound (CEUS) can be used to detect biliary ischaemia, but no study has examin
Autor:
Yang Yang, Laien Song, Hui Tang, Linsen Ye, Qing Yang, Binsheng Fu, Tong Zhang, Jinming Wei, Shu-hong Yi, Yingcai Zhang
Publikováno v:
J Gastrointest Oncol
Background This study aimed to investigate the relationship between the prognosis of patients with hepatocellular carcinoma (HCC) after liver transplantation and mammalian target of rapamycin (mTOR) pathway-related genes-TSC1/2. Methods We retrospect
Autor:
Cong Du, Hui Zhao, Tong Zhang, Binsheng Fu, Shu-hong Yi, Qi Zhang, Jian Zhang, Jun Zheng, Tongyu Lu, Jian-rong Liu, Yingcai Zhang, Jianye Cai, Jiebin Zhang, Andy Peng Xiang, Liang Chen, Guoying Wang, Gui-hua Chen, Yang Yang, Wenjie Chen, Jia Yao, Hua Li, Huimin Yi, Gen-shu Wang
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-15 (2021)
Stem Cell Research & Therapy
Stem Cell Research & Therapy
Background ABO-incompatible liver transplantation (ABO-i LT) has become a rescue therapeutic option for patients with severe hepatic failure. Although the use of rituximab greatly reduces the morbidity of antibody-mediated rejection (AMR), severe adv
Publikováno v:
Bioengineered, Vol 11, Iss 1, Pp 1016-1026 (2020)
Bioengineered
article-version (VoR) Version of Record
Bioengineered
article-version (VoR) Version of Record
Dysregulation of long noncoding RNAs (lncRNAs) has been suggested to foster the carcinogenesis of hepatocellular carcinoma (HCC). To date, the role of long intergenic noncoding RNA01134 (LINC01134) in HCC have never been researched yet. Herein, we fo
Publikováno v:
Liver Research, Vol 5, Iss 1, Pp 33-35 (2021)
Patients with recurrent hepatocellular carcinoma (HCC) following liver transplantation (LT) have a poor prognosis owing to rapid tumor progression. Yttrium-90 radioembolization (90Y-RE) has been shown to be a safe and efficacious transarterial radioe